Houlihan Lokey is one of the world's leading independent investment banks, consistently ranked among the top global advisors by transaction count. Because the firm earns advisory fees tied directly to deal activity, its quarterly results serve as a real-time barometer of corporate M&A, capital markets, and restructuring conditions. The second quarter carried extra weight after a disappointing fiscal first quarter, when revenue fell about 16% year over year and both revenue and EPS missed consensus. With shares trading well below their 52-week high and global deal volumes under pressure, investors were looking for evidence that fee generation had stabilized and that the firm's diversified platform could regain momentum. I also checked this using Tickeron’s AI Screener to see how the stock compares to others in the industry.
Houlihan Lokey reported revenue of $692 million for the second quarter of fiscal 2027, up from $659 million in the prior-year period and ahead of the roughly $626 million Wall Street consensus. The result represented a meaningful sequential improvement from the fiscal first quarter's $511 million, reflecting a partial recovery in advisory fee generation.
Net income came in at $110 million, essentially flat versus $111 million a year earlier and a notable rebound from the $78 million reported in the prior quarter. Operating income was $154 million, compared with $151 million in the year-ago period.
On a per-share basis, diluted EPS rebounded sharply from the fiscal first quarter's $1.35 adjusted figure, which had missed the $1.64 consensus. Heading into the report, analysts had modeled roughly $1.63 in adjusted EPS, though the company's adjusted results include add-backs for acquisition-related amortization and other non-recurring items. Management's discussion centered on fee events across its Corporate Finance, Financial Restructuring, and Financial and Valuation Advisory segments, as well as the strength of its new-business pipeline. From what I see, the sequential rebound points to better fee conversion in the period.
Investor sentiment entering the quarter was cautious. HLI shares had declined from a 52-week high above $200 to the low-$130s as global M&A activity cooled, and the prior quarter's miss had raised concerns about whether weakening deal flow was beginning to weigh on fee generation and conversion rates. Analysts broadly maintained a constructive longer-term view, with a "Moderate Buy" consensus and an average price target near $155, but near-term conviction was limited, with EPS estimates holding essentially flat in the weeks leading up to the report. The second quarter's return to year-over-year revenue growth and stable net income was viewed as an early sign of stabilization, though the market's focus remained on whether the improved momentum could be sustained into the back half of the fiscal year.
Looking ahead, investors will be watching several signals closely. First, the durability of the M&A recovery is paramount. Global deal volumes softened in recent quarters, and whether announced transactions convert into completed fee events will determine revenue trajectory over the next several quarters.
Second, management's commentary on the pipeline and backlog across Corporate Finance will be critical. A strengthening advisory pipeline, combined with recovering private-equity and sponsor activity, would support the view that the firm's market-leading position by deal count can translate into revenue resilience.
Third, the Financial Restructuring segment remains a potential offset. If corporate distress accelerates, restructuring and liability-management mandates could provide a counterweight to any slowdown in traditional M&A work.
Finally, investors should monitor margin and cost trends, particularly the compensation ratio, which is a key profitability lever for advisory firms. The company's ability to balance hiring and retention against near-term revenue fluctuations will shape profitability as the fiscal year progresses. I’m watching this closely as the next few quarters unfold.
In my view, tools like Tickeron’s AI Screener have become a regular part of how I review quarterly results. It helps filter for comparable firms in the financial services space based on technical patterns, fundamentals, and AI signals, giving additional context to how HLI stacks up against peers. The platform’s customizable scans make it easier to identify trends in advisory and restructuring names without manually sorting through dozens of reports. This kind of insight supports a more disciplined approach to following names like this one.
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
Sergey Savastiouk, Ph.D. has a degree in Applied Mathematics from Moscow University and has extensive experience as an entrepreneur, investor, manager, and mathematician. His professional expertise is in applied mathematics, mathematical modeling, system and pattern analysis, and software and hardware system integration. He has served as the CEO of several hi-tech start-up companies and nonprofit organizations, which has given him proven capabilities in business strategy for high-tech start-up companies, market assessment, company formation, team building, product development, marketing, and sales. He has published numerous articles in journals and magazines on related fields. As a retail investor, he spent 15 years developing his proprietary trading and quantitative algorithms (now Tickeron’s A.I.), which brought him significant returns in trading the stock market. His current work and goal in founding Tickeron is to bring professional, sophisticated stock market analysis capabilities to retail investors via an easy-to-use interface.
HLI moved below its 50-day moving average on November 20, 2026 date and that indicates a change from an upward trend to a downward trend. In 29 of 42 similar past instances, the stock price decreased further within the following month. The odds of a continued downward trend are 69%.
The 10-day RSI Indicator for HLI moved out of overbought territory on November 05, 2026. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 38 similar instances where the indicator moved out of overbought territory. In 24 of the 38 cases, the stock moved lower in the following days. This puts the odds of a move lower at 63%.
The Momentum Indicator moved below the 0 level on November 16, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on HLI as a result. In 46 of 83 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 55%.
The Moving Average Convergence Divergence Histogram (MACD) for HLI turned negative on November 13, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 39 similar instances when the indicator turned negative. In 21 of the 39 cases the stock turned lower in the days that followed. This puts the odds of success at 54%.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where HLI declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 62%.
The Stochastic Oscillator shows that the ticker has stayed in the oversold zone for 4 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an upward trend is expected.
The 10-day moving average for HLI crossed bullishly above the 50-day moving average on October 28, 2026. This indicates that the trend has shifted higher and could be considered a buy signal. In 9 of 16 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are 56%.
Following a +5.20% 3-day Advance, the price is estimated to grow further. Considering data from situations where HLI advanced for three days, in 202 of 353 cases, the price rose further within the following month. The odds of a continued upward trend are 57%.
HLI may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.
The Aroon Indicator entered an Uptrend today. In 135 of 246 cases where HLI Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are 55%.
The Tickeron SMR rating for this company is 49 (best 1 - 100 worst), indicating strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Price Growth Rating for this company is 55 (best 1 - 100 worst), indicating steady price growth. HLI’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron PE Growth Rating for this company is 66 (best 1 - 100 worst), pointing to average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Profit vs. Risk Rating rating for this company is 66 (best 1 - 100 worst), indicating well-balanced risk and returns. The average Profit vs. Risk Rating rating for the industry is 89, placing this stock slightly better than average.
The Tickeron Valuation Rating of 81 (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (4.520) is normal, around the industry mean (3.143). P/E Ratio (23.911) is within average values for comparable stocks, (6.733). Projected Growth (PEG Ratio) (0.210) is also within normal values, averaging (0.809). Dividend Yield (0.019) settles around the average of (8.975) among similar stocks. P/S Ratio (3.517) is also within normal values, averaging (17.075).
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows
a provider of investment banking services
Industry InvestmentBanksBrokers